Login / Signup

Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors.

Manuel Silva-CarmonaTiphanie P VogelSarah MarchalMyriam GuesmiJean-Christophe DubusSylvie LeroyAlexandre FabreVincent BarlogisLisa R ForbesLisa Giovannini-Chami
Published in: American journal of respiratory and critical care medicine (2020)
Keyphrases
  • interstitial lung disease
  • systemic sclerosis
  • rheumatoid arthritis
  • idiopathic pulmonary fibrosis
  • cell proliferation